DYN — Dyne Therapeutics, Inc.
Materials · Pharmaceutical Preparations · Nasdaq
3Insiders filing
5Transactions
+$0Reported buys
−$248kReported sells
1Cluster events
Cluster membership
| Week | Window | Tier | Dir | Insiders | Total value |
|---|---|---|---|---|---|
| 2026-W37 | 2026-09-08 → 2026-09-08 | WATCH | − sell | 3 | $135k |
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Kerr Douglas | Chief Medical Officer | 2 | $116k |
| Cox John | CEO & President | 1 | $107k |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2 | $25k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-08 | DYN | Friedl-Naderer Johanna Chief Commercial Officer 10b5-1 | S | 185 | $18.88 | −$3k | ✓ Cluster clu-7fc91edd0363 |
| 2026-09-08 | 2026-09-08 | DYN | Kerr Douglas Chief Medical Officer 10b5-1 | S | 1,290 | $18.88 | −$24k | ✓ Cluster clu-7fc91edd0363 |
| 2026-09-08 | 2026-09-08 | DYN | Cox John CEO & President 10b5-1 | S | 5,658 | $18.88 | −$107k | ✓ Cluster clu-7fc91edd0363 |
| 2026-09-08 | 2026-09-04 | DYN | Friedl-Naderer Johanna Chief Commercial Officer 10b5-1 | S | 900 | $24.35 | −$22k | |
| 2026-09-08 | 2026-09-04 | DYN | Kerr Douglas Chief Medical Officer 10b5-1 | S | 3,745 | $24.35 | −$91k |
No transactions match these filters.